Clinical Trial Assessing the HERV-W Env Antagonist GNbAC1 for Efficacy in MS

Clinical trial NCT02782858 · COMPLETED

Trial details

NCT number: NCT02782858
Sponsor: GeNeuro SA
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Sclerosis, Relapsing-Remitting

Start date: 2016-04-01
Primary completion: 2017-08-01
Enrollment: 270

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.